| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
171,465 |
156,496 |
$31.69M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
237,370 |
218,845 |
$19.54M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
138,891 |
119,630 |
$4.00M |
| 70450 |
Computed tomography, head or brain; without contrast material |
11,945 |
11,611 |
$2.78M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
48,801 |
45,493 |
$2.18M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
63,304 |
56,519 |
$1.93M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
23,322 |
21,889 |
$1.89M |
| 80053 |
Comprehensive metabolic panel |
139,331 |
126,360 |
$1.82M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,337 |
6,205 |
$1.78M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,676 |
15,694 |
$1.44M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
29,162 |
23,246 |
$1.31M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
887 |
886 |
$1.29M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
134,748 |
121,484 |
$1.27M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
8,156 |
7,928 |
$1.18M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
11,290 |
9,076 |
$1.15M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
19,278 |
16,270 |
$1.10M |
| 0450 |
Emergency room services |
9,868 |
8,772 |
$1.08M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
10,785 |
9,462 |
$1.06M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,247 |
2,222 |
$740K |
| 71046 |
Radiologic examination, chest; 2 views |
24,618 |
24,091 |
$709K |
| 84484 |
|
42,595 |
36,992 |
$690K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,004 |
1,001 |
$680K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,583 |
6,241 |
$607K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,043 |
3,978 |
$571K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
6,479 |
6,389 |
$562K |
| 83880 |
|
17,153 |
16,458 |
$534K |
| 59425 |
|
5,947 |
3,932 |
$533K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
174,173 |
89,282 |
$462K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
14,207 |
4,504 |
$462K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,286 |
1,273 |
$430K |
| J9271 |
Injection, pembrolizumab, 1 mg |
110 |
84 |
$418K |
| 97799 |
|
9,243 |
1,938 |
$383K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,518 |
1,515 |
$379K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,947 |
7,916 |
$362K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,711 |
4,514 |
$339K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,079 |
3,998 |
$333K |
| Z7502 |
|
8,683 |
8,526 |
$328K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,281 |
1,277 |
$315K |
| 71045 |
Radiologic examination, chest; single view |
23,638 |
22,623 |
$315K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
411 |
409 |
$315K |
| 83690 |
|
36,294 |
34,726 |
$313K |
| 82553 |
|
24,309 |
22,993 |
$311K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,408 |
1,405 |
$305K |
| 81025 |
|
29,085 |
28,163 |
$293K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
21,912 |
19,039 |
$285K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
690 |
689 |
$284K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,621 |
6,860 |
$282K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,834 |
2,792 |
$276K |
| 93971 |
|
1,601 |
1,568 |
$267K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25,477 |
24,551 |
$266K |
| 99215 |
Prolong outpt/office vis |
2,928 |
2,871 |
$265K |
| 99205 |
Prolong outpt/office vis |
2,249 |
1,919 |
$264K |
| 70486 |
|
959 |
946 |
$263K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,792 |
1,761 |
$261K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,806 |
4,500 |
$255K |
| 87040 |
|
11,879 |
10,272 |
$238K |
| 81001 |
|
55,948 |
53,634 |
$227K |
| 93976 |
|
700 |
690 |
$223K |
| 86803 |
|
11,903 |
11,495 |
$219K |
| 86703 |
|
12,138 |
11,712 |
$214K |
| 76801 |
|
2,544 |
2,347 |
$212K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
22,899 |
21,828 |
$210K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
825 |
813 |
$209K |
| 82550 |
|
29,342 |
27,573 |
$207K |
| 70496 |
|
778 |
772 |
$204K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,198 |
2,100 |
$198K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,590 |
2,586 |
$194K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,927 |
9,041 |
$190K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,161 |
1,160 |
$186K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,925 |
1,921 |
$184K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,166 |
7,992 |
$178K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,302 |
1,270 |
$177K |
| 96367 |
|
4,039 |
2,599 |
$176K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,267 |
3,083 |
$176K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
255 |
254 |
$172K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,696 |
2,665 |
$168K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
123 |
122 |
$159K |
| 83605 |
|
10,800 |
10,070 |
$154K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,764 |
7,535 |
$152K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,152 |
3,086 |
$150K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,122 |
3,060 |
$149K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,325 |
1,324 |
$146K |
| 71250 |
|
532 |
529 |
$142K |
| 97165 |
|
1,610 |
913 |
$140K |
| 76770 |
|
1,234 |
1,227 |
$136K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
9,606 |
7,912 |
$135K |
| Z9725 |
|
3,078 |
3,038 |
$132K |
| 92551 |
|
6,812 |
6,795 |
$126K |
| 72131 |
|
443 |
441 |
$124K |
| 76830 |
Ultrasound, transvaginal |
1,227 |
1,213 |
$121K |
| 85730 |
|
17,774 |
17,311 |
$118K |
| 90686 |
|
6,882 |
6,844 |
$112K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,699 |
8,997 |
$112K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,158 |
1,715 |
$111K |
| 90715 |
|
2,778 |
2,770 |
$110K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
49 |
37 |
$110K |
| 70498 |
|
775 |
768 |
$108K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,144 |
10,860 |
$106K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,488 |
497 |
$105K |
| 72100 |
|
2,247 |
2,233 |
$102K |
| 84702 |
|
4,993 |
4,272 |
$100K |
| 99199 |
Unlisted special service, procedure or report |
1,903 |
1,665 |
$99K |
| J3490 |
Unclassified drugs |
6,149 |
3,469 |
$99K |
| 73221 |
|
146 |
146 |
$99K |
| 72141 |
|
118 |
118 |
$97K |
| 99243 |
|
1,025 |
1,005 |
$93K |
| 85610 |
|
20,197 |
19,371 |
$92K |
| 82962 |
|
31,494 |
25,775 |
$91K |
| 80061 |
Lipid panel |
5,427 |
5,347 |
$89K |
| 93970 |
|
346 |
341 |
$89K |
| 76641 |
|
823 |
823 |
$89K |
| 73030 |
|
2,261 |
2,225 |
$88K |
| 74178 |
|
256 |
255 |
$88K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,520 |
1,512 |
$86K |
| 87186 |
|
5,154 |
4,811 |
$84K |
| J1756 |
Injection, iron sucrose, 1 mg |
500 |
214 |
$84K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,440 |
1,056 |
$83K |
| 73130 |
|
2,071 |
2,048 |
$82K |
| 29880 |
|
53 |
53 |
$80K |
| J1815 |
Injection, insulin, per 5 units |
1,866 |
1,231 |
$80K |
| 73562 |
|
2,164 |
2,147 |
$77K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
981 |
976 |
$76K |
| 85027 |
|
9,192 |
8,488 |
$76K |
| 86592 |
|
13,547 |
13,001 |
$75K |
| 73610 |
|
1,746 |
1,728 |
$73K |
| 73630 |
|
1,822 |
1,795 |
$72K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
764 |
711 |
$69K |
| J1750 |
Injection, iron dextran, 50 mg |
366 |
240 |
$68K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,663 |
1,659 |
$68K |
| 87077 |
|
4,866 |
4,518 |
$67K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,113 |
8,066 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,793 |
4,703 |
$67K |
| 86141 |
|
4,327 |
4,167 |
$66K |
| 81003 |
|
22,262 |
21,695 |
$65K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,971 |
5,390 |
$64K |
| 96417 |
|
1,490 |
942 |
$64K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
199 |
171 |
$62K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
745 |
697 |
$61K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,985 |
5,530 |
$61K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
592 |
552 |
$61K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
126 |
81 |
$61K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,351 |
1,264 |
$55K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,500 |
4,876 |
$51K |
| 76870 |
|
524 |
515 |
$50K |
| 84439 |
|
4,083 |
4,035 |
$50K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,493 |
6,377 |
$50K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,038 |
3,397 |
$50K |
| 82803 |
|
1,621 |
1,513 |
$49K |
| 90651 |
|
1,474 |
1,472 |
$48K |
| 59025 |
Fetal non-stress test |
913 |
834 |
$48K |
| 73110 |
|
1,179 |
1,159 |
$46K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,140 |
1,139 |
$46K |
| 84466 |
|
2,484 |
2,421 |
$43K |
| 72040 |
|
1,041 |
1,037 |
$43K |
| 73502 |
|
950 |
943 |
$42K |
| 86850 |
|
3,379 |
3,248 |
$42K |
| 97014 |
|
1,958 |
710 |
$40K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
267 |
246 |
$40K |
| 82248 |
|
6,178 |
4,741 |
$40K |
| 74018 |
|
1,355 |
1,316 |
$40K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
403 |
386 |
$39K |
| 90670 |
|
1,736 |
1,726 |
$38K |
| 71101 |
|
535 |
530 |
$38K |
| 77066 |
Tomosynthesis, mammo |
212 |
212 |
$37K |
| 96415 |
|
1,314 |
829 |
$36K |
| 82728 |
|
1,954 |
1,899 |
$36K |
| 99152 |
|
484 |
483 |
$35K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
220 |
117 |
$34K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,998 |
1,882 |
$34K |
| 82150 |
|
4,015 |
3,915 |
$34K |
| 87631 |
|
385 |
381 |
$33K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
405 |
370 |
$33K |
| 73080 |
|
754 |
745 |
$32K |
| 76536 |
|
393 |
392 |
$32K |
| 82805 |
|
463 |
441 |
$29K |
| 99173 |
|
5,092 |
5,084 |
$29K |
| 36415 |
Collection of venous blood by venipuncture |
20,795 |
17,233 |
$29K |
| 84703 |
|
2,831 |
2,755 |
$29K |
| J2060 |
Injection, lorazepam, 2 mg |
3,188 |
2,571 |
$29K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
48 |
48 |
$28K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
287 |
287 |
$28K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
295 |
260 |
$27K |
| 99153 |
Mod sedat endo service >5yrs |
1,431 |
1,427 |
$25K |
| 83735 |
|
3,182 |
2,789 |
$25K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
845 |
305 |
$24K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
178 |
178 |
$24K |
| 85007 |
|
5,137 |
4,634 |
$24K |
| 83540 |
|
2,637 |
2,572 |
$23K |
| 90723 |
|
1,508 |
1,500 |
$23K |
| 86901 |
|
5,457 |
5,185 |
$22K |
| 90677 |
|
353 |
353 |
$21K |
| 85379 |
|
1,750 |
1,707 |
$21K |
| 87081 |
|
2,154 |
2,135 |
$21K |
| 82378 |
|
842 |
666 |
$21K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,601 |
1,510 |
$20K |
| 90647 |
|
1,347 |
1,342 |
$20K |
| 90633 |
|
1,313 |
1,295 |
$20K |
| 77386 |
|
90 |
14 |
$20K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,083 |
1,679 |
$20K |
| 86900 |
|
4,986 |
4,759 |
$19K |
| 77085 |
|
309 |
309 |
$19K |
| 84145 |
|
711 |
681 |
$19K |
| 82010 |
|
1,848 |
1,687 |
$19K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
512 |
506 |
$19K |
| 87522 |
Neg quan hep c or qual rna |
521 |
496 |
$18K |
| 87070 |
|
1,462 |
1,447 |
$18K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,315 |
1,278 |
$18K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,920 |
1,772 |
$18K |
| 11721 |
|
3,387 |
2,417 |
$18K |
| 73590 |
|
569 |
565 |
$18K |
| 81002 |
|
11,314 |
9,432 |
$18K |
| 80164 |
|
945 |
905 |
$17K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
499 |
499 |
$17K |
| 80305 |
|
1,922 |
1,867 |
$17K |
| 82746 |
|
842 |
834 |
$17K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
69 |
66 |
$17K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,739 |
1,176 |
$15K |
| 70491 |
|
46 |
45 |
$14K |
| J9190 |
Injection, fluorouracil, 500 mg |
428 |
145 |
$13K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
17 |
17 |
$13K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
436 |
434 |
$12K |
| 73090 |
|
411 |
406 |
$12K |
| 90680 |
|
835 |
834 |
$12K |
| 94729 |
|
193 |
193 |
$12K |
| 82140 |
|
758 |
696 |
$12K |
| J0185 |
Injection, aprepitant, 1 mg |
45 |
25 |
$12K |
| 73560 |
|
450 |
448 |
$12K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,470 |
1,373 |
$12K |
| 96368 |
|
403 |
278 |
$11K |
| 93458 |
|
13 |
13 |
$11K |
| 74019 |
|
317 |
312 |
$11K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
105 |
37 |
$11K |
| 94060 |
|
229 |
229 |
$11K |
| 77334 |
|
55 |
40 |
$10K |
| 90734 |
|
563 |
563 |
$10K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
445 |
210 |
$10K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
102 |
102 |
$9K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$9K |
| 72072 |
|
160 |
159 |
$9K |
| 93798 |
|
359 |
55 |
$9K |
| 90710 |
|
457 |
457 |
$9K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
426 |
387 |
$8K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
871 |
458 |
$8K |
| 96523 |
|
399 |
371 |
$8K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
493 |
386 |
$7K |
| 90733 |
|
61 |
61 |
$7K |
| 73140 |
|
280 |
278 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
443 |
424 |
$7K |
| 90750 |
|
43 |
42 |
$7K |
| 78227 |
|
13 |
13 |
$7K |
| 72110 |
|
102 |
102 |
$7K |
| 84100 |
|
1,352 |
1,253 |
$7K |
| 82043 |
|
875 |
872 |
$7K |
| 86300 |
|
313 |
226 |
$7K |
| 82607 |
|
428 |
418 |
$7K |
| 85652 |
|
1,924 |
1,828 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
601 |
568 |
$7K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
625 |
491 |
$6K |
| 86780 |
|
708 |
689 |
$6K |
| J1644 |
Injection, heparin sodium, per 1000 units |
977 |
496 |
$6K |
| 85014 |
|
2,975 |
2,945 |
$6K |
| 96411 |
|
215 |
133 |
$6K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
256 |
181 |
$6K |
| J1953 |
Injection, levetiracetam, 10 mg |
249 |
217 |
$6K |
| 90696 |
|
347 |
347 |
$5K |
| 96416 |
|
72 |
42 |
$5K |
| 90716 |
|
264 |
260 |
$5K |
| 94726 |
|
85 |
85 |
$5K |
| 90707 |
|
236 |
231 |
$5K |
| 76642 |
|
51 |
51 |
$5K |
| 70487 |
|
12 |
12 |
$5K |
| 97162 |
|
302 |
300 |
$5K |
| 73564 |
|
104 |
104 |
$5K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
14 |
14 |
$4K |
| 0270 |
|
4,897 |
2,332 |
$4K |
| 73120 |
|
172 |
170 |
$4K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
55 |
28 |
$4K |
| 90620 |
|
198 |
198 |
$4K |
| 83615 |
|
507 |
477 |
$4K |
| 99384 |
|
33 |
33 |
$4K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
13 |
12 |
$4K |
| 97116 |
|
197 |
124 |
$4K |
| Z7610 |
|
1,326 |
932 |
$4K |
| 84550 |
|
638 |
613 |
$4K |
| 11720 |
|
446 |
431 |
$4K |
| J1940 |
Injection, furosemide, up to 20 mg |
436 |
369 |
$4K |
| 94644 |
|
127 |
122 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
99 |
99 |
$4K |
| 83655 |
|
287 |
285 |
$4K |
| 99383 |
|
35 |
35 |
$3K |
| 82570 |
|
455 |
436 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,443 |
3,234 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
476 |
448 |
$3K |
| J1071 |
Injection, testosterone cypionate, 1 mg |
1,634 |
998 |
$3K |
| 77080 |
|
70 |
70 |
$3K |
| V2632 |
Posterior chamber intraocular lens |
31 |
30 |
$3K |
| 90656 |
|
187 |
187 |
$3K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
145 |
114 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
987 |
657 |
$3K |
| 59430 |
|
29 |
29 |
$3K |
| 80074 |
|
55 |
55 |
$3K |
| 77336 |
|
41 |
25 |
$3K |
| 92523 |
|
14 |
14 |
$3K |
| 82247 |
|
331 |
251 |
$2K |
| 0250 |
|
727 |
368 |
$2K |
| 72192 |
|
15 |
15 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
56 |
55 |
$2K |
| 71271 |
|
13 |
13 |
$2K |
| 71020 |
|
68 |
57 |
$2K |
| 94727 |
|
55 |
55 |
$2K |
| 87340 |
|
347 |
337 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
220 |
185 |
$2K |
| 90700 |
|
146 |
145 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
40 |
40 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
225 |
222 |
$2K |
| 73600 |
|
70 |
69 |
$2K |
| 72128 |
|
12 |
12 |
$2K |
| 87149 |
|
88 |
78 |
$2K |
| 74220 |
|
39 |
39 |
$2K |
| 11056 |
|
337 |
297 |
$2K |
| 73100 |
|
67 |
64 |
$2K |
| 73620 |
|
68 |
67 |
$2K |
| 90685 |
|
107 |
107 |
$2K |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
139 |
129 |
$2K |
| 77065 |
Tomosynthesis, mammo |
13 |
13 |
$2K |
| 95816 |
|
25 |
25 |
$2K |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
174 |
154 |
$2K |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
14 |
12 |
$2K |
| 87634 |
|
17 |
17 |
$2K |
| 86480 |
|
52 |
52 |
$1K |
| 97750 |
|
26 |
16 |
$1K |
| 84156 |
|
256 |
243 |
$1K |
| 0760 |
|
46 |
43 |
$1K |
| 11055 |
|
159 |
156 |
$1K |
| A9150 |
Non-prescription drugs |
2,148 |
1,066 |
$1K |
| 85018 |
|
571 |
549 |
$967.38 |
| 99386 |
|
12 |
12 |
$934.48 |
| 82105 |
|
37 |
36 |
$931.02 |
| 85045 |
|
157 |
138 |
$880.86 |
| 73552 |
|
31 |
31 |
$867.53 |
| 73060 |
|
28 |
28 |
$852.73 |
| 87205 |
|
132 |
130 |
$768.68 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
29 |
24 |
$766.17 |
| 76881 |
|
15 |
15 |
$736.51 |
| 86334 |
|
53 |
52 |
$705.00 |
| 96379 |
|
4,880 |
2,035 |
$683.75 |
| 84153 |
|
39 |
39 |
$682.09 |
| 97161 |
|
28 |
27 |
$672.61 |
| 86580 |
|
168 |
166 |
$609.47 |
| 87420 |
|
30 |
26 |
$538.02 |
| 85384 |
|
40 |
38 |
$534.59 |
| J1836 |
Injection, metronidazole, 10 mg |
70 |
48 |
$527.49 |
| 17110 |
|
68 |
55 |
$485.20 |
| 86593 |
|
102 |
100 |
$453.35 |
| Z7500 |
|
13 |
12 |
$443.30 |
| 82274 |
|
21 |
21 |
$424.83 |
| 86920 |
|
14 |
14 |
$419.10 |
| 87147 |
|
50 |
49 |
$415.74 |
| 87493 |
|
277 |
270 |
$412.80 |
| 73070 |
|
13 |
13 |
$401.35 |
| 20610 |
|
59 |
40 |
$376.82 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
43 |
31 |
$350.92 |
| 73000 |
|
13 |
13 |
$344.89 |
| 72170 |
|
12 |
12 |
$335.49 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
14 |
12 |
$299.29 |
| 82375 |
|
15 |
15 |
$286.00 |
| 87210 |
|
34 |
34 |
$283.54 |
| 80076 |
|
26 |
26 |
$282.52 |
| 86706 |
|
18 |
17 |
$243.36 |
| 86038 |
|
14 |
14 |
$203.60 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
36 |
33 |
$200.21 |
| 84165 |
|
43 |
41 |
$195.00 |
| 0001A |
|
13 |
13 |
$194.83 |
| 86702 |
|
12 |
12 |
$182.57 |
| 86039 |
|
16 |
16 |
$160.00 |
| 96376 |
|
540 |
412 |
$156.29 |
| 76882 |
|
12 |
12 |
$155.07 |
| 82009 |
|
31 |
31 |
$149.21 |
| 86701 |
|
12 |
12 |
$122.51 |
| 99070 |
|
54 |
28 |
$115.80 |
| 83521 |
|
13 |
12 |
$113.48 |
| 82272 |
|
42 |
41 |
$98.21 |
| 80177 |
|
14 |
12 |
$96.00 |
| 86762 |
|
12 |
12 |
$84.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,836 |
1,830 |
$65.17 |
| 11057 |
|
15 |
13 |
$58.28 |
| 81000 |
|
14 |
14 |
$29.49 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,443 |
1,382 |
$21.09 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
139 |
138 |
$13.32 |
| J2704 |
Injection, propofol, 10 mg |
13 |
13 |
$12.17 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
26 |
25 |
$5.25 |
| 94760 |
|
781 |
762 |
$1.95 |
| Z1034 |
|
984 |
661 |
$0.00 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
39 |
37 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
14 |
14 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
22 |
22 |
$0.00 |
| Z6400 |
|
14 |
14 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
16 |
15 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
33 |
33 |
$0.00 |
| 90653 |
|
12 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
22 |
17 |
$0.00 |